Nvelop Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Nvelop Therapeutics?

Nvelop Therapeutics has 4 investors including Newpath Management And Atlas Venture.

Q: How much funding has Nvelop Therapeutics raised to date?

Nvelop Therapeutics has raised obfuscated.

Overview

Nvelop Therapeutics

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Nvelop Therapeutics

CB Rank

59409

Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.

Acquired by

nChroma Bio

Founded

obfuscation

Private

Seed

Cambridge, Massachusetts, United States

51-100

www.nveloptx.com

Biotechnology

Genetics

Medical

Funding Rounds

Seed

OBF

obfuscation

Key People

J. Keith Joung: Scientific Co-Founder and Consultant
Past Role: Verve Therapeutics, Scientific Co-Founder & Consultant

Details

Legal Name

Nvelop Therapeutics, Inc.

Operating Status

Closed

Company Type

For Profit

Founders

J. Keith Joung

About the Company

Nvelop Therapeutics focuses on creating advanced, programmable delivery systems designed for efficient in vivo gene editing and therapeutic cargo delivery. The company combines epigenetic editing technologies with next-generation delivery methods to address unmet medical needs.

Contact Email

office.ceohq@gmail.com

Predictions & Insights

Growth Insight

See this Growth Insight

Nvelop Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

DLVR-X

A modular, non-viral delivery platform engineered for tissue-specific in vivo delivery of diverse therapeutic cargoes including transiently expressed ribonucleoproteins.

DLVR-M

A modular, non-viral delivery platform with minimal or no viral proteins, engineered for tissue-specific in vivo delivery and efficient gene editing with a fully humanized architecture.

Research & Development

Nvelop Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed
obfuscated obfuscation	Seed Round - Nvelop Therapeutics	4	obfuscated obfuscation	Newpath Management	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Newpath Management	Yes	Seed Round - Nvelop Therapeutics	—
Newpath Management	Yes	Seed Round - Nvelop Therapeutics	—
Newpath Management	Yes	Seed Round - Nvelop Therapeutics	—
Newpath Management	Yes	Seed Round - Nvelop Therapeutics	—
Newpath Management	Yes	Seed Round - Nvelop Therapeutics	—